Nuveen
SRNE

Nuveen’s Sorrento Therapeutics, Inc. SRNE Stock Holding History

Nuveen’s Portfolio SRNE Stock Details SRNE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-2,833,364
Closed -$2.51M – 3172
2022
Q4 		$2.51M Buy
2,833,364
+729,384
+35% +$968K ﹤0.01% 2283
2022
Q3 		$3.3M Buy
2,103,980
+556,799
+36% +$1.26M ﹤0.01% 2133
2022
Q2 		$3.11M Buy
1,547,181
+522,509
+51% +$903K ﹤0.01% 2209
2022
Q1 		$2.57M Buy
1,024,672
+78,729
+8% +$246K ﹤0.01% 2388
2021
Q4 		$5.66M Sell
945,943
-144,002
-13% -$894K ﹤0.01% 2043
2021
Q3 		$8.99M Sell
1,089,945
-125,802
-10% -$1.07M ﹤0.01% 1855
2021
Q2 		$11.8M Buy
1,215,747
+113,284
+10% +$902K ﹤0.01% 1758
2021
Q1 		$9.12M Sell
1,102,463
-173,671
-14% -$1.83M ﹤0.01% 1854
2020
Q4 		$8.71M Buy
1,276,134
+60,315
+5% +$484K ﹤0.01% 1797
2020
Q3 		$13.6M Buy
1,215,819
+390,089
+47% +$3.57M 0.01% 1310
2020
Q2 		$5.18M Buy
825,730
+312,194
+61% +$1.2M ﹤0.01% 1876
2020
Q1 		$945K Buy
513,536
+16,212
+3% +$46.7K ﹤0.01% 2534
2019
Q4 		$1.68M Sell
497,324
-44,864
-8% -$107K ﹤0.01% 2495
2019
Q3 		$1.16M Buy
542,188
+93,448
+21% +$218K ﹤0.01% 2636
2019
Q2 		$1.2M Buy
+448,740
New +$1.61M ﹤0.01% 2664

Other funds holding SRNE

PP
Paloma Partners Greenwich, Connecticut $1.36B AUM 249.29% 1-Year Est. Return
OCM
Oaktree Capital Management Los Angeles, California $7.21B AUM 45.97% 1-Year Est. Return
OFA
Oaktree Fund Advisors Los Angles, California $57.8M AUM 67.22% 1-Year Est. Return
CGA
Crescent Grove Advisors Lake Forest, Illinois $1.2B AUM 23.08% 1-Year Est. Return
LCM
Lattice Capital Management Kirkland, Washington $49.5M AUM 28.58% 1-Year Est. Return
STB
S&T Bank Indiana, Pennsylvania $333M AUM 106.39% 1-Year Est. Return
GA
GoalVest Advisory New York $539M AUM 27.49% 1-Year Est. Return
HFRG
Houlihan Financial Resource Group Ashburn, Virginia $281M AUM 17.68% 1-Year Est. Return
VFA
Valeo Financial Advisors Carmel, Indiana $4.74B AUM 27.69% 1-Year Est. Return
GBWM
Granite Bay Wealth Management Portsmouth, New Hampshire $1.09B AUM 22.93% 1-Year Est. Return

Nuveen's SRNE Position: Q1 2023 in Review

Nuveen sold out of Sorrento Therapeutics, Inc. (SRNE) in Q1 2023, closing a stake of 2,833,364 shares — an estimated $2.51M sold.

Nuveen first reported a position in SRNE in Q2 2019 and held it in 15 quarters. The position peaked at $13.6M in Q3 2020. 34 funds tracked by Wall St. Rank hold SRNE as of Q1 2023.

  • Nuveen reported no remaining Sorrento Therapeutics, Inc. position as of Q1 2023 after selling out during the quarter.
  • Nuveen sold 2,833,364 Sorrento Therapeutics, Inc. shares in Q1 2023, an estimated $2.51M.
  • Nuveen first reported a position in Sorrento Therapeutics, Inc. in Q2 2019 and held it in 15 quarters.
  • Nuveen's Sorrento Therapeutics, Inc. position peaked at $13.6M in Q3 2020.
  • 34 funds tracked by Wall St. Rank held Sorrento Therapeutics, Inc. as of Q1 2023.

Based on Nuveen's 13F filing for Q1 2023, filed 15 May 2023.